EBIT at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s EBIT?
- Kyverna Therapeutics, Inc. (KYTX) reported EBIT of -$41.37M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s EBIT changed year-over-year?
- Kyverna Therapeutics, Inc.'s EBIT increased by 12.7% year-over-year, from -$47.41M to -$41.37M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s EBIT?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s EBIT has grown at a 65.0% compound annual growth rate (CAGR), from -$62.41M to -$169.83M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.